SLITRK4 is a protein implicated in the development and maintenance of neural circuits, and its activation is influenced by a variety of chemical compounds through specific signaling pathways. For instance, certain small molecules can elevate intracellular cAMP levels, which is a critical second messenger in various signaling cascades, thereby enhancing neuronal differentiation and neurite outgrowth processes that are associated with SLITRK4 function. Furthermore, the activation of protein kinase C through other compounds can lead to phosphorylation events, which then influence synaptic formation and maintenance, processes where SLITRK4 is known to play a significant role. Additionally, inhibition of certain enzymes that degrade cAMP can result in a compensatory upregulation of signaling pathways, subsequently promoting SLITRK4 function.
Other molecules operate by modulating the ionic balance within neurons, which indirectly influences SLITRK4 activity. Calcium signaling is integral to neuronal function, and agents that increase intracellular calcium may activate calcium-dependent pathways that SLITRK4 is part of, thereby enhancing its role in neuron morphology. Conversely, compounds that block ion channels could lead to an upregulation of compensatory mechanisms that increase SLITRK4 activity, thus supporting synaptic connectivity. Moreover, alterations in neuronal excitability through the opening of specific ion channels can also indirectly support the role of SLITRK4 in neuroplasticity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which can phosphorylate downstream targets that may influence SLITRK4's role in synaptic formation and maintenance. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
Inhibits protein kinase A, potentially leading to compensatory mechanisms that upregulate SLITRK4 function in neuronal communication. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase 4 inhibitor, preventing cAMP breakdown, potentially enhancing SLITRK4-mediated signaling in neurodevelopmental processes. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
cAMP analog that activates cAMP-dependent pathways, potentially promoting SLITRK4 activity in neuronal growth and plasticity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which could activate calcium-dependent pathways that enhance SLITRK4 function in neuron morphology. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that increases cAMP, potentially promoting SLITRK4 activity related to synaptic formation and neuron-to-neuron signaling. | ||||||
Diazoxide | 364-98-7 | sc-200980 | 1 g | $300.00 | 5 | |
Opens ATP-sensitive potassium channels, potentially altering neuronal excitability and indirectly enhancing SLITRK4's role in neuroplasticity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
L-type calcium channel blocker, which could lead to changes in intracellular signaling, indirectly promoting SLITRK4's involvement in synaptic modulation. | ||||||
Glycine | 56-40-6 | sc-29096A sc-29096 sc-29096B sc-29096C | 500 g 1 kg 3 kg 10 kg | $41.00 $71.00 $112.00 $357.00 | 15 | |
Acts as an inhibitory neurotransmitter, potentially modulating neuronal circuits in a way that necessitates increased SLITRK4 activity for homeostasis. | ||||||